title: Biliary duct stones: percutaneous transhepatic removal.
abstract: Percutaneous transhepatic removal of common bile duct stones was performed 57 times in 53 patients with a success rate of 93%. All patients had contraindications to surgery or had undergone unsuccessful attempts at endoscopic retrograde cholangiopancreatography and papillotomy. A modified Dormia basket was inserted through a percutaneous transhepatic approach and the stones or fragments were advanced into the duodenum. Monooctanoin (26 patients) or methyl tertiary butyl ether (4 patients) was infused to reduce stone size or remove residual debris. The average time for complete stone removal was 8.5 days. Morbidity was 12% and mortality was 4%, results which compare favorably with those of surgery.
authors.affiliation: Department of Diagnostic Radiology, New England Deaconess Hospital, Boston, MA 02215.
authors.forename: K R
authors.initials: KR
authors.lastname: Stokes
authors.forename: M E
authors.initials: ME
authors.lastname: Clouse
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002210:Caprylates; D002758:Cholangiography / Q000295:instrumentation / Q000379:methods; D002769:Cholelithiasis / Q000628:therapy*; D004987:Ethers / Q000008:administration & dosage; D042882:Gallstones / Q000628:therapy; D005989:Glycerides / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008096:Lithotripsy / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D008738:Methyl Ethers; D008875:Middle Aged; D010195:Pancreatitis / Q000209:etiology; D012997:Solvents / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D002210:Caprylates; D004987:Ethers; D005989:Glycerides; D008738:Methyl Ethers; D012997:Solvents; C043243:methyl tert-butyl ether; C025343:monooctanoin